Stopping antidepressants safely.

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Long-term antidepressant use often exceeds recommended durations, particularly in women.
• Evidence for sustained benefit in mild-to-moderate depression is limited, while adverse effects increase over time.
• Antidepressant withdrawal symptoms are common, affecting at least half of patients upon discontinuation.

Purpose of the Study:

• To outline a practical, patient-centered approach for the deprescribing of antidepressants.
• To guide clinicians in tailoring tapering strategies based on individual risk and clinical response.
• To differentiate withdrawal symptoms from depressive relapse and manage challenging presentations.

Main Methods:

• A patient-centered approach to antidepressant deprescribing.
• Tailoring tapering to individual risk factors and clinical response.
• Utilizing gradual dose reduction, potentially over months or years, with close monitoring.

Main Results:

• Small average symptom improvement over placebo in randomized trials (approx. 2 points on HDRS).
• Estimated number needed to treat (NNT) of 7-10 for clinically meaningful benefit.
• High incidence of withdrawal symptoms (at least 50%) with risk increasing with dose and duration.

Conclusions:

• Abrupt antidepressant discontinuation should be avoided to minimize harm.
• Gradual, individualized tapering, possibly using liquid formulations or dissolving tablets, is recommended for higher-risk patients.
• Patient education, shared decision-making, and informed consent are vital for safe and effective antidepressant discontinuation.